Soon mushrooms with medicinal values are going to be available at markets. Looking at the vast medicinal scope in Ganoderma mushroom, scientists here at CSA University have resolved to start its' production at large scale.
According to scientists whose work has been published by Indian Council of Agriculture Research (ICAR), 'Ganoderma lucidium' a species of mushroom has the nutrients that have the efficacy of anti viral, anti tumour and it is immunity enhancer.
Besides, it has the medicinal qualities like anti-inflammatory, blood pressure control, cardio-vascular, lower cholesterol, kidney anti-toxic agents, asthma/bronchial, stress reduction and this species of mushroom has the potential to control liver/hepatitis and chitin.
Of the 14000 to 15,000 species of mushrooms in the world, around 700 have known for medicinal properties and Ganoderma mushroom is one such variety that according to scientists has the efficacy to cure chronic diseases including cancer and HIV.
"We have discovered it as good medicinal food because of its' quality of containing substance that are immunity enhancer. In the country 30-35 mushroom species are under cultivation.
We have decided to grow ganoderma mushroom for commercial usage," said Dr Ved Ratan, in charge mushroom and associate professor at Chandra Shekhar Azad (CSA) University of agriculture and technology here.
Incidentally scientists here at CSA campus discovered a Ganoderma mushroom grew near a tree. Perhaps that was the day when scientists here had made up their find to start the large-scale production.
Scientists said that this mushroom is useful against cancers of stomach and oesophagus, lungs etc. Countries like China, Russia, Japan, Korea as well as US and Canada have understood the medicinal significance of ganoderma mushroom.
Corroborating his claim Dr Ved Ratan said, "Several anti-tumour polysaccharides such as hetero-beta-glucans and their proteins complexes (eg. Xyloglucans and acidic beta-glucan containing uronic acid), as well as dietary fibres, lectins and terpenoids have been isolated from medicinal mushrooms in other countries."
He informed that in Japan, China, Russia and the USA several different polysaccharides anti-tumour agents have been developed from the fruiting body, mycelia and culture medium of various medicinal mushrooms.
These are lentinula edodes, ganoderma lucidium and schizophyllum commune. Dr Ved Ratan said, "We are testing the local substrate to ensure that in which concentrate ganoderma mushrooms grow well. In very near future we will make available the spawn of this mushroom."